Two cases of acute respiratory failure following SARS‐CoV‐2 vaccination in post‐COVID‐19 pneumonia
Abstract Severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) vaccination is a very effective method of preventing infection and is recommended for people having recovered from coronavirus disease 2019 (COVID‐19). In this novel case report, we describe two patients with post‐COVID‐19 pneumon...
| Main Authors: | , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2022-08-01
|
| Series: | Respirology Case Reports |
| Subjects: | |
| Online Access: | https://doi.org/10.1002/rcr2.995 |
| _version_ | 1818160910951251968 |
|---|---|
| author | Tomohiro Bando Reoto Takei Yoshikazu Mutoh Hajime Sasano Yasuhiko Yamano Toshiki Yokoyama Toshiaki Matsuda Kensuke Kataoka Tomoki Kimura Yasuhiro Kondoh |
| author_facet | Tomohiro Bando Reoto Takei Yoshikazu Mutoh Hajime Sasano Yasuhiko Yamano Toshiki Yokoyama Toshiaki Matsuda Kensuke Kataoka Tomoki Kimura Yasuhiro Kondoh |
| author_sort | Tomohiro Bando |
| collection | DOAJ |
| description | Abstract Severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) vaccination is a very effective method of preventing infection and is recommended for people having recovered from coronavirus disease 2019 (COVID‐19). In this novel case report, we describe two patients with post‐COVID‐19 pneumonia who experienced acute respiratory failure and new bilateral ground‐glass opacities several days after receiving SARS‐CoV‐2 vaccination. Both patients were treated with methylprednisolone pulse therapy and recovered from the disease successfully. Indeed, post‐COVID‐19 patients can gain benefits from the vaccine, but vaccination at the early stage of recovery from COVID‐19 might be a risk for certain populations. These cases highlight a potential association between vaccination, interstitial lung disease and worsening of post‐COVID‐19 pneumonia. Further investigation and research examining the relationship between the timing of SARS‐CoV‐2 vaccination and potential risks in post‐COVID‐19 patients is recommended. |
| first_indexed | 2024-12-11T16:09:23Z |
| format | Article |
| id | doaj.art-d7be73755c044b4e8db7afe77ba1ce40 |
| institution | Directory Open Access Journal |
| issn | 2051-3380 |
| language | English |
| last_indexed | 2024-12-11T16:09:23Z |
| publishDate | 2022-08-01 |
| publisher | Wiley |
| record_format | Article |
| series | Respirology Case Reports |
| spelling | doaj.art-d7be73755c044b4e8db7afe77ba1ce402022-12-22T00:59:06ZengWileyRespirology Case Reports2051-33802022-08-01108n/an/a10.1002/rcr2.995Two cases of acute respiratory failure following SARS‐CoV‐2 vaccination in post‐COVID‐19 pneumoniaTomohiro Bando0Reoto Takei1Yoshikazu Mutoh2Hajime Sasano3Yasuhiko Yamano4Toshiki Yokoyama5Toshiaki Matsuda6Kensuke Kataoka7Tomoki Kimura8Yasuhiro Kondoh9Department of Respiratory Medicine and Allergy Tosei General Hospital Seto JapanDepartment of Respiratory Medicine and Allergy Tosei General Hospital Seto JapanDepartment of Infectious Diseases Tosei General Hospital Seto JapanDepartment of Respiratory Medicine and Allergy Tosei General Hospital Seto JapanDepartment of Respiratory Medicine and Allergy Tosei General Hospital Seto JapanDepartment of Respiratory Medicine and Allergy Tosei General Hospital Seto JapanDepartment of Respiratory Medicine and Allergy Tosei General Hospital Seto JapanDepartment of Respiratory Medicine and Allergy Tosei General Hospital Seto JapanDepartment of Respiratory Medicine and Allergy Tosei General Hospital Seto JapanDepartment of Respiratory Medicine and Allergy Tosei General Hospital Seto JapanAbstract Severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) vaccination is a very effective method of preventing infection and is recommended for people having recovered from coronavirus disease 2019 (COVID‐19). In this novel case report, we describe two patients with post‐COVID‐19 pneumonia who experienced acute respiratory failure and new bilateral ground‐glass opacities several days after receiving SARS‐CoV‐2 vaccination. Both patients were treated with methylprednisolone pulse therapy and recovered from the disease successfully. Indeed, post‐COVID‐19 patients can gain benefits from the vaccine, but vaccination at the early stage of recovery from COVID‐19 might be a risk for certain populations. These cases highlight a potential association between vaccination, interstitial lung disease and worsening of post‐COVID‐19 pneumonia. Further investigation and research examining the relationship between the timing of SARS‐CoV‐2 vaccination and potential risks in post‐COVID‐19 patients is recommended.https://doi.org/10.1002/rcr2.995acute exacerbation of interstitial lung diseaseCOVID‐19interstitial lung diseasevaccination |
| spellingShingle | Tomohiro Bando Reoto Takei Yoshikazu Mutoh Hajime Sasano Yasuhiko Yamano Toshiki Yokoyama Toshiaki Matsuda Kensuke Kataoka Tomoki Kimura Yasuhiro Kondoh Two cases of acute respiratory failure following SARS‐CoV‐2 vaccination in post‐COVID‐19 pneumonia Respirology Case Reports acute exacerbation of interstitial lung disease COVID‐19 interstitial lung disease vaccination |
| title | Two cases of acute respiratory failure following SARS‐CoV‐2 vaccination in post‐COVID‐19 pneumonia |
| title_full | Two cases of acute respiratory failure following SARS‐CoV‐2 vaccination in post‐COVID‐19 pneumonia |
| title_fullStr | Two cases of acute respiratory failure following SARS‐CoV‐2 vaccination in post‐COVID‐19 pneumonia |
| title_full_unstemmed | Two cases of acute respiratory failure following SARS‐CoV‐2 vaccination in post‐COVID‐19 pneumonia |
| title_short | Two cases of acute respiratory failure following SARS‐CoV‐2 vaccination in post‐COVID‐19 pneumonia |
| title_sort | two cases of acute respiratory failure following sars cov 2 vaccination in post covid 19 pneumonia |
| topic | acute exacerbation of interstitial lung disease COVID‐19 interstitial lung disease vaccination |
| url | https://doi.org/10.1002/rcr2.995 |
| work_keys_str_mv | AT tomohirobando twocasesofacuterespiratoryfailurefollowingsarscov2vaccinationinpostcovid19pneumonia AT reototakei twocasesofacuterespiratoryfailurefollowingsarscov2vaccinationinpostcovid19pneumonia AT yoshikazumutoh twocasesofacuterespiratoryfailurefollowingsarscov2vaccinationinpostcovid19pneumonia AT hajimesasano twocasesofacuterespiratoryfailurefollowingsarscov2vaccinationinpostcovid19pneumonia AT yasuhikoyamano twocasesofacuterespiratoryfailurefollowingsarscov2vaccinationinpostcovid19pneumonia AT toshikiyokoyama twocasesofacuterespiratoryfailurefollowingsarscov2vaccinationinpostcovid19pneumonia AT toshiakimatsuda twocasesofacuterespiratoryfailurefollowingsarscov2vaccinationinpostcovid19pneumonia AT kensukekataoka twocasesofacuterespiratoryfailurefollowingsarscov2vaccinationinpostcovid19pneumonia AT tomokikimura twocasesofacuterespiratoryfailurefollowingsarscov2vaccinationinpostcovid19pneumonia AT yasuhirokondoh twocasesofacuterespiratoryfailurefollowingsarscov2vaccinationinpostcovid19pneumonia |